Related references
Note: Only part of the references are listed.Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction
Andrew R. Kompa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists
Sayuri N. Friedland et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Use of a Soluble Epoxide Hydrolase Inhibitor in Smoke-Induced Chronic Obstructive Pulmonary Disease
Lei Wang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids
Christophe Morisseau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Evaluation of the Effects of Urotensin II and Soluble Epoxide Hydrolase Inhibitor on Skin Microvessel Tone in Healthy Controls and Heart Failure Patients
Lavinia Tran et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential Hypertension
Jeremy Bellien et al.
CIRCULATION (2012)
Homocysteine Upregulates Soluble Epoxide Hydrolase in Vascular Endothelium In Vitro and In Vivo
Donghong Zhang et al.
CIRCULATION RESEARCH (2012)
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Charles N. Serhan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Diet-Induced Metabolic Syndrome in Rats
Abishek Iyer et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Emerging drugs for chronic obstructive pulmonary disease
Maria Gabriella Matera et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Delivery of AAV2-CYP2J2 Protects Remnant Kidney in the 5/6-Nephrectomized Rat via Inhibition of Apoptosis and Fibrosis
Gang Zhao et al.
HUMAN GENE THERAPY (2012)
Soluble epoxide hydrolase and ischemic cardiomyopathy
Ting-Ting Zhao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single- and Multiple-Dose Studies in Healthy Human Subjects
Dawn Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
EPOXIDES AND SOLUBLE EPOXIDE HYDROLASE IN CARDIOVASCULAR PHYSIOLOGY
John D. Imig
PHYSIOLOGICAL REVIEWS (2012)
The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases
Xizhen Xu et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats
Houli Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats
Alexandra Sporkova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation
Pei H. Cui et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The cytochrome P450 pathway in angiogenesis and endothelial cell biology
Ingrid Fleming
CANCER AND METASTASIS REVIEWS (2011)
Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy
Hiromi Inoue et al.
CANCER BIOLOGY & THERAPY (2011)
Soluble Epoxide Hydrolase Inhibitors and Heart Failure
Hong Qiu et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes
Wei Pang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
R. H. Ingraham et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Cytochrome P450 eicosanoids and cerebral vascular function
John D. Imig et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice
Yangmei Deng et al.
FASEB JOURNAL (2011)
Genetic Variation in Soluble Epoxide Hydrolase (EPHX2) Is Associated With Forearm Vasodilator Responses in Humans
Craig R. Lee et al.
HYPERTENSION (2011)
Stable EET urea agonist and soluble epoxide hydrolase inhibitor regulate rat pulmonary arteries through TRPCs
Yun Liu et al.
HYPERTENSION RESEARCH (2011)
Cytochrome P450-Derived Epoxyeicosatrienoic Acids and Pulmonary Hypertension: Central Role of Transient Receptor Potential C6 Channels
Annemarieke E. Loot et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats
Zuzana Honetschlaegerova et al.
JOURNAL OF HYPERTENSION (2011)
Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase
Annette Cronin et al.
JOURNAL OF LIPID RESEARCH (2011)
Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening
Li Xing et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and Structure-Activity Relationship Studies of Urea-Containing Pyrazoles as Dual Inhibitors of Cyclooxygenase-2 and Soluble Epoxide Hydrolase
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
Christian Brenneis et al.
MOLECULAR PAIN (2011)
Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
Jeremy Bellien et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP
Bora Inceoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance
Ayala Luria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception
Karen Wagner et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
17,18-Epoxyeicosatetraenoic Acid Targets PPARγ and p38 Mitogen-Activated Protein Kinase to Mediate Its Anti-inflammatory Effects in the Lung
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Advances in eicosanoid research, novel therapeutic implications
Jesper Z. Haeggstrom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model
Jun-Yan Liu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism
Donghong Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase
Anne B. Eldrup et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats
Vera Certikova Chabova et al.
CLINICAL SCIENCE (2010)
Epoxyeicosatrienoic Acid Analogs and Vascular Function
V. Sudhahar et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Pharmacological inhibition of the soluble epoxide hydrolase - from mouse to man
Marc Revermann
CURRENT OPINION IN PHARMACOLOGY (2010)
Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs
Hsing-Ju Tsai et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
Jan M. Williams et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Epoxyeicosatrienoic Acids: Novel Mediators of Cardioprotection
Kasem Nithipatikom et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids
Christophe Morisseau et al.
JOURNAL OF LIPID RESEARCH (2010)
Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation
Yangmei Deng et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
Pengcheng Luo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue
Bart M. De Taeye et al.
OBESITY (2010)
Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease
Oliver Jung et al.
PLOS ONE (2010)
Epoxyeicosatrienoic acids and endothelium-dependent responses
William B. Campbell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands
Philippe de Medina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events
Jun-Yan Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Alexis N. Simpkins et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Mammalian epoxide hydrolases in xenobiotic metabolism and signalling
Martina Decker et al.
ARCHIVES OF TOXICOLOGY (2009)
Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice
Hantz C. Hercule et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia
Le-Ning Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors
Hong C. Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors
Hong C. Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Joseph P. Marino
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Arachidonic acid cytochrome P450 epoxygenase pathway
Arthur A. Spector
JOURNAL OF LIPID RESEARCH (2009)
Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
Anne B. Eldrup et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition
J. R. Falck et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches
Ning Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation
David J. Behm et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice
Komal Sodhi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo
Jun-Yan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
DISTRIBUTION OF SOLUBLE AND MICROSOMAL EPOXIDE HYDROLASE IN THE MOUSE BRAIN AND ITS CONTRIBUTION TO CEREBRAL EPOXYEICOSATRIENOIC ACID METABOLISM
A. Marowsky et al.
NEUROSCIENCE (2009)
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy
Ding Ai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
EET displays anti-inflammatory effects in TNF-α-stimulated human bronchi
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
The COXIB Experience: A Look in the Rearview Mirror
Lawrence J. Marnett
Annual Review of Pharmacology and Toxicology (2008)
Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2
Hiromasa Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Development of metabolically stable inhibitors of mammalian microsomal epoxide hydrolase
Christophe Morisseau et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model
Arzu Ulu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Distribution and expression of soluble epoxide hydrolase in human brain
Priyanka Sura et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase
Beubei Luo et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of β-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray
Maia Terashvili et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease
Jan Monti et al.
NATURE GENETICS (2008)
Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
Bora Inceoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation
Michael P. Hutchens et al.
RESUSCITATION (2008)
Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α
Valerie Y. Ng et al.
DRUG METABOLISM AND DISPOSITION (2007)
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo
Ding Ai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice
Ayala Luria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: Use for studies of metabolism and ligand binding
Wenqi Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
Nipavan Chiamvimonvat et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain
Bora Inceoglu et al.
LIFE SCIENCES (2006)
Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Julien Becker et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors
Kara R. Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels
Jeffrey J. Olearczyk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease
Martin Spiecker et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature
Anuradha Dhanasekaran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis
AE Enayetallah et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The antiinflammatory effect of laminar flow:: The role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase
Y Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase
KL Tran et al.
BIOCHEMISTRY (2005)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor
KR Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis
GA Gomez et al.
BIOCHEMISTRY (2004)
Design, synthesis, and biological activity of 1,3-Disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility
IH Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Vascular localization of soluble epoxide hydrolase in the human kidney
ZG Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries
KM Gauthier et al.
PHARMACOLOGICAL RESEARCH (2004)
Polymorphisms in human soluble epoxide hydrolase
BD Przybyla-Zawislak et al.
MOLECULAR PHARMACOLOGY (2003)
The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity
JW Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Involvement of CYP2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells
S Viswanathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats
M Fornage et al.
HYPERTENSION (2002)
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases
C Morisseau et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms
M Sandberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
